The Road to BIO: Day 5
Monday, June 12, 2017
South Carolina /// Georgia
South Carolina. A state rich in culture, history and, to our delight, science! According to SCBio.org, there are more than 572 biotech companies in the state, employing over 13,500 people, with the state’s life science sector as a whole comprising approximately 1,300 companies.
Making Our Way Through Phase II
Our Road to BIO, we’re cautiously optimistic to say, has been relatively smooth, though it probably doesn’t hurt that we caught a weekend to gain some momentum. We hit a few bumps in the road during our early discovery phase through the Northeast Biotech Corridor, but got a service boost after making our way through Clinical Trails in Appalachia. We’re about to turn the corner toward the final phases of our journey, but still have a lot of road to cover before we claim victory.
DISTANCE SCHEDULED THIS MORNING: 183 miles
We’re kicking off our tour of the Deep South in the port city of Charleston, consistently among the top in the country for the import and export of motor vehicles for transporting people. We are pleased to be contributing to that statistic today, as we power onward through our journey in the Lamborghini Aventador and stop to learn about our partners’ various journeys across the supply chain, toward #BIO2017. Grab a sweet tea and join us!
After our third fuel stop and first service stop, we are back on the Road to BIO 2017. View the highlights from day 3 of our journey through DC, Virginia and Tennessee.
James E. Gregory, President & CEO of UPM Pharmaceuticals, discusses the benefits of being a family-owned CDMO in terms of flexibility and transparency
Ed Scholtz, Ph.D., Vice President of R&D, UPM Pharmaceuticals, shares how UPM’s rich history as an R&D company helps inform of potential gaps early on in the development process
To join us on the Road to BIO, view all of our daily videos.